Hard to swallow

December 15, 2006

I see that investors in Pfizer are stunned by a fall of more than £15 billion in the value of the drug company after trials of the cholesterol-lowering drug Torcetrapib were stopped.

In clinical trials there were 60 per cent more deaths in the group taking the animal-tested drug than in the group given a placebo. Perhaps investors should support our campaign.

Pat Rattigan
Director, British Anti-Vivisection Association

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please Login or Register to read this article.